Kinaxis Inc. (TSE:KXS - Get Free Report) has been given a consensus rating of "Buy" by the six research firms that are currently covering the firm, MarketBeat reports. Six investment analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is C$200.00.
Several research analysts recently weighed in on KXS shares. National Bank Financial dropped their price objective on shares of Kinaxis from C$240.00 to C$200.00 and set an "outperform" rating for the company in a research report on Wednesday, May 27th. BMO Capital Markets upped their price objective on Kinaxis from C$180.00 to C$185.00 in a report on Friday, May 8th. Canadian Imperial Bank of Commerce increased their price objective on Kinaxis from C$173.00 to C$205.00 in a research report on Friday, June 5th. Stifel Nicolaus lowered their target price on Kinaxis from C$245.00 to C$200.00 and set a "buy" rating for the company in a research note on Wednesday, May 6th. Finally, Royal Bank Of Canada boosted their target price on Kinaxis from C$200.00 to C$210.00 and gave the stock an "outperform" rating in a research report on Friday, May 8th.
Check Out Our Latest Analysis on KXS
Insider Transactions at Kinaxis
In other Kinaxis news, Director Robert G. Courteau sold 5,010 shares of the company's stock in a transaction dated Friday, May 29th. The shares were sold at an average price of C$151.39, for a total transaction of C$758,463.90. Following the transaction, the director directly owned 32,945 shares in the company, valued at approximately C$4,987,543.55. This represents a 13.20% decrease in their position. Also, insider Conrad John Mandala sold 924 shares of the company's stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of C$137.14, for a total transaction of C$126,717.36. Following the transaction, the insider owned 820 shares in the company, valued at approximately C$112,454.80. The trade was a 52.98% decrease in their ownership of the stock. Over the last quarter, insiders sold 35,934 shares of company stock valued at $5,328,181. Corporate insiders own 1.20% of the company's stock.
Kinaxis Stock Performance
TSE:KXS opened at C$154.81 on Monday. The stock has a market capitalization of C$4.23 billion, a P/E ratio of 52.66, a price-to-earnings-growth ratio of 3.60 and a beta of 0.73. The company has a current ratio of 1.72, a quick ratio of 2.29 and a debt-to-equity ratio of 12.15. Kinaxis has a 1 year low of C$117.22 and a 1 year high of C$212.45. The firm has a 50 day moving average of C$152.04 and a 200-day moving average of C$146.77.
Kinaxis (TSE:KXS - Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The company reported C$1.45 earnings per share for the quarter. Kinaxis had a net margin of 14.48% and a return on equity of 19.72%. The firm had revenue of C$230.19 million during the quarter. As a group, sell-side analysts anticipate that Kinaxis will post 4.2526231 EPS for the current fiscal year.
Kinaxis Company Profile
(
Get Free Report)
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain - from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kinaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.
While Kinaxis currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.